Alexandra Kropotova

Alexandra Kropotova

Chief Tech/Sci/R&D Officer at SAB BIOTHERAPEUTICS, INC.

Net worth: 140 208 $ as of 2026-10-30

53 year
Health Technology
Consumer Services

Profile

Dr. Alexandra Kropotova is a Chief Medical Officer & Executive Vice President at SAB Biotherapeutics, Inc. and an Independent Director at iBio, Inc. She is on the Board of Directors at iBio, Inc. Dr. Kropotova was previously employed as a VP-Global Specialty Research & Development by Teva Pharmaceuticals, Inc., a Vice President-Strategy & Head-Strategic Planning by Sanofi, and a Director & Head-Global Clinical Respiratory by Pfizer Inc. She received her MBA from Ohio University Graduate College and a doctorate degree from Pacific State Medical University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-09-16 41,853 ( 0.05% ) 140 208 $ 2026-10-30
2026-10-13 0 ( -.--% ) - $ 2026-10-30

Alexandra Kropotova active positions

CompaniesPositionStart
SAB BIOTHERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2022-06-05
IBIO, INC. Director/Board Member 2020-10-13

Former positions of Alexandra Kropotova

CompaniesPositionEnd
Corporate Officer/Principal 2022-05-31
SANOFI Corporate Officer/Principal 2015-12-31
PFIZER INC. Director/Board Member 2006-12-31
See the detail of Alexandra Kropotova's experience

Education of Alexandra Kropotova

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

86

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Alexandra Kropotova